JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JMS-17-2 impairs metastatic seeding and colonization of breast cancer cells[1].
Molecular Weight:
419.95
Purity:
99.59
CAS Number:
[1380392-05-1]
Formula:
C25H26ClN3O
Target:
CX3CR1
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted